Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Citi
UBS
Covington
Accenture
McKinsey

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 7,713,986

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,713,986
Title:Compounds and methods for treatment of chemotherapy-induced anemia
Abstract: The invention relates to methods and compounds for treating chemotherapy-induced anemia. In particular, methods for treating chemotherapy-induced anemia in subjects refractory to treatment with recombinant human erythropoietin are encompassed herein.
Inventor(s): Seeley; Todd W. (Moraga, CA), Liu; David Y. (Palo Alto, CA), Klaus; Stephen J. (San Francisco, CA)
Assignee: FibroGen, Inc. (San Francisco, CA)
Application Number:11/455,200
Patent Claims:see list of patent claims

Details for Patent 7,713,986

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial FibroGen, Inc. (San Francisco, CA) 2036-04-30 RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial FibroGen, Inc. (San Francisco, CA) 2036-04-30 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial FibroGen, Inc. (San Francisco, CA) 2036-04-30 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial FibroGen, Inc. (San Francisco, CA) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chubb
Fish and Richardson
McKinsey
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.